English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Results There was no significant difference between groups that underwent on-pump coronary bypass surgery in terms of mean units of blood and blood products used (p > 0.05). The percentage of blood product use was 54.5% in salicylate receivers and 55.6% in non-receivers. There was no significant difference between groups of patients that underwent off-pump beating heart coronary surgery in terms of amount of blood and blood product used (p > 0.05). The percentage of blood product use was 37.5% in salicylate receivers and 50% in non-receivers in this group of patients (p > 0.05). Conclusions When the amount blood and blood products used was investigated for patients undergoing either on-pump or off-pump coronary bypass in terms of salicylate use, no significant difference was detected between groups.

Comparison of amount of postoperative use of blood and blood products between patients receiving and not receiving salicylate before coronary surgery